Xcout Intel
VILLYA LLC competitors & alternatives
The 12 closest competitors and alternatives to VILLYA LLC among pharmaceuticals companies — ranked by similarity to what VILLYA LLC actually does, not by market-cap band.
Subscribe to see VILLYA LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About VILLYA LLC
Villya LLC is a pharmaceutical company that develops second-generation medications and proprietary delivery technologies aimed at improving the function, solubility, and administration of traditional drugs and peptides. Using patented technology, the company focuses on creating water-soluble formulations and alternative delivery methods, including oral options for treatments such as Praziquantel, Sildenafil, Semaglutide, and insulin.
VILLYA LLC at a glance
VILLYA LLC is a pharmaceuticals company headquartered in United States. Its most recent funding round, Series A, raised $71M in June 2024. Xcout tracks 2 named people at VILLYA LLC, including Sreeshailam Aare (CSO (CHIEF SCIENTIFIC OFFICER)).
VILLYA LLC leadership
- Sreeshailam AareCSO (CHIEF SCIENTIFIC OFFICER)
- William MillerCEO (CHIEF EXECUTIVE OFFICER)
VILLYA LLC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $71M | 14 named | |
| SEC Form D filing | $250,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 VILLYA LLC competitors
Ranked by semantic similarity — how close each company is to VILLYA LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Pila Pharma AB is a clinical-stage biotechnology company that develops oral TRPV1 antagonists as potential treatments for obesity and diabetes. The company serves patients suffering from these metabolic conditions by advancing innovative, non-injectable drug candidates through preclinical and clinical research.
Biotechnology & Pharmaceuticals
Vesalius Longevity Labs operates a B2Doctor platform that provides peptide therapeutics and related products exclusively to licensed healthcare providers and clinical networks. The company manufactures and distributes peptides across multiple delivery formats—including subcutaneous, transdermal, intranasal, oral, and topical—utilizing cGMP-aligned manufacturing and third-party verification.
Similar pharmaceuticals company
Smartech Topical, Inc. is a specialty pharmaceutical company that develops patented delivery technology for topical pharmaceutical healthcare solutions. The company focuses on advancing pharmaceutical deliverables across key healthcare categories to improve consumer health and wellbeing.
Similar pharmaceuticals company
Wegovy provides semaglutide injections and pills for weight management and weight loss in adults with obesity or overweight. The company offers product options, dosing information, guidance, and savings resources for patients.
Similar pharmaceuticals company
Vigonvita Life Sciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for neuropsychiatry, reproductive health, and viral infection therapeutic areas. Its products include LV232, a first-in-class dual-target 5-HTT/5-HT modulators, which is in Phase II of clinical trial for the treatment of depressive disorder; and TPN171, a type-5 phosphodiesterase inhibitor completed Phase III clinical trial for the treatment of erectile dysfunction. The company also develops VV116, a RNA-dependent RNA polymerase inhibitor completed a Phase II clinical trial for the treatment of respiratory syncytial virus infection, as well as COVID-19 infections; TPN102, a novel antiepileptic drug, which is in Phase I clinical trial for the treatment of epilepsy; VV119, a multi-target serotonin-dopamine activity modulator, which is in Phase I clinical trial for the treatment of psychiatric disorders and schizophrenia; VV261, a novel nucleoside prodrug, which is in Phase I clinical trial for chikungunya, coronaviruses, influenza, and arena virus. In addition, it develops VV913, a novel investigational drug candidate for premature ejaculation; VV147 for the treatment of major depressive disorder; and VV207 for the treatment of adenovirus infection. The company was incorporated in 2013 and is headquartered in Suzhou, China.
Similar pharmaceuticals company
J2 Bio-Pharma, LLC is a specialty pharmaceutical company that reformulates neurology medications to address unmet medical needs. The company partners with pharmacies, patients, and businesses in the healthcare sector to develop and commercialize therapeutic products.
Similar pharmaceuticals company
Novilla Pharmaceuticals is a biotechnology company headquartered in Cambridge, Massachusetts, developing a novel class of localized medicines designed by AI to treat pain. The firm focuses on targeted therapeutics that function only where needed within the body. It operates as a privately held startup with a small scientific team.
Similar pharmaceuticals company
InstaPill Private Limited is a pharmaceutical contract development and manufacturing organization (CDMO) specializing in advanced lyophilized orally disintegrating tablets (ODTs).
Similar pharmaceuticals company
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Similar pharmaceuticals company
Milla Pharmaceuticals Inc. is the U.S. subsidiary of the Belgian pharmaceutical group A.forall, specializing in the commercialization and distribution of FDA-approved injectable medications. The company serves wholesalers, distributors, hospitals, and infusion care clinics across the United States to provide access to affordable generic and institutional pharmaceutical products.
Similar pharmaceuticals company
APPCO Pharma LLC is a U.S.-based pharmaceutical company that provides drug development, manufacturing, and analytical services. It offers formulation development, manufacturing, and analytical validation services for pharmaceutical products, while introducing high-quality and affordable drug products to the market.
Similar pharmaceuticals company
Helus Pharma Inc. advances mental health treatments by developing novel, second-generation therapies, proprietary drug delivery systems, and patent-protected molecules. The company serves the healthcare and pharmaceutical sectors.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of VILLYA LLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for VILLYA LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →